SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-143412"
 

Search: onr:"swepub:oai:DiVA.org:uu-143412" > Forgoing artificial...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003545naa a2200481 4500
001oai:DiVA.org:uu-143412
003SwePub
008110120s2007 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:115937097
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1434122 URI
024a https://doi.org/10.1016/j.jpainsymman.2006.12.0062 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1159370972 URI
040 a (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Buiting, Hilde M.4 aut
2451 0a Forgoing artificial nutrition or hydration in patients nearing death in six European countries
264 1b Elsevier BV,c 2007
338 a print2 rdacarrier
520 a Whether or not artificial nutrition or hydration (ANH) may be forgone in terminally ill patients has been the subject of medical and ethical discussions. Information about the frequency and background characteristics of making decisions to forgo ANH is generally limited to specific clinical settings. The aim of this study was to compare the Practice of forgoing ANH in six European countries: Belgium, Denmark, Italy, The Netherlands, Sweden, and Switzerland. In each country, random samples were drawn from death registries. Subsequently, the reporting physician received a questionnaire about the medical decisions that preceded the patient's death. The total number of deaths studied was 20,480. The percentage of all deaths that were preceded by a decision to forgo ANH varied from 2.6% in Italy to 10.9% in The Netherlands. In most countries, decisions to forgo ANH were more frequently made for female patients, patients aged 80 years or older, and for patients who died of a malignancy or disease of the nervous system (including dementia). Of patients in whom ANH was forgone, 67%-93% were incompetent. Patients in whom ANH was forgone did not receive more potentially life-shorlening drugs to relieve symptoms than other Patients for whom other end-of-life decisions had been made. Decisions to forgo ANH are made in a substantial percentage of terminally ill patients. Providing all patients who are in the terminal stage of a lethal disease with ANH does not seem to be a widely accepted standard among physicians in Western Europe.
653 a withholding/withdrawing treatment
653 a artificial nutrition or hydration
653 a decision making
653 a end of life
653 a MEDICINE
653 a MEDICIN
700a van Delden, Johannes J. M.4 aut
700a Rietjens, Judith A. C.4 aut
700a Onwuteaka-Philipsen, Bregje D.4 aut
700a Bilsen, Johan4 aut
700a Fischer, Susanne4 aut
700a Löfmark, Ruriku Karolinska Institutet,Uppsala universitet,Centrum för forsknings- och bioetik4 aut0 (Swepub:uu)rulof957
700a Miccinesi, Guido4 aut
700a Norup, Michael4 aut
700a van der Heide, Agnes4 aut
710a Uppsala universitetb Centrum för forsknings- och bioetik4 org
773t Journal of Pain and Symptom Managementd : Elsevier BVg 34:3, s. 305-314q 34:3<305-314x 0885-3924x 1873-6513
856u http://www.jpsmjournal.com/article/S0885392407003363/pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-143412
8564 8u https://doi.org/10.1016/j.jpainsymman.2006.12.006
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:115937097

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view